Cargando…

High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue

Engineered biphasic osteochondral tissues may have utility in cartilage defect repair. As bone-marrow-derived mesenchymal stem/stromal cells (MSC) have the capacity to make both bone-like and cartilage-like tissues, they are an ideal cell population for use in the manufacture of osteochondral tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Babur, Betul Kul, Futrega, Kathryn, Lott, William B., Klein, Travis Jacob, Cooper-White, Justin, Doran, Michael Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550660/
https://www.ncbi.nlm.nih.gov/pubmed/25924853
http://dx.doi.org/10.1007/s00441-015-2159-y
_version_ 1782387478966042624
author Babur, Betul Kul
Futrega, Kathryn
Lott, William B.
Klein, Travis Jacob
Cooper-White, Justin
Doran, Michael Robert
author_facet Babur, Betul Kul
Futrega, Kathryn
Lott, William B.
Klein, Travis Jacob
Cooper-White, Justin
Doran, Michael Robert
author_sort Babur, Betul Kul
collection PubMed
description Engineered biphasic osteochondral tissues may have utility in cartilage defect repair. As bone-marrow-derived mesenchymal stem/stromal cells (MSC) have the capacity to make both bone-like and cartilage-like tissues, they are an ideal cell population for use in the manufacture of osteochondral tissues. Effective differentiation of MSC to bone-like and cartilage-like tissues requires two unique medium formulations and this presents a challenge both in achieving initial MSC differentiation and in maintaining tissue stability when the unified osteochondral tissue is subsequently cultured in a single medium formulation. In this proof-of-principle study, we used an in-house fabricated microwell platform to manufacture thousands of micropellets formed from 166 MSC each. We then characterized the development of bone-like and cartilage-like tissue formation in the micropellets maintained for 8–14 days in sequential combinations of osteogenic or chondrogenic induction medium. When bone-like or cartilage-like micropellets were induced for only 8 days, they displayed significant phenotypic changes when the osteogenic or chondrogenic induction medium, respectively, was swapped. Based on these data, we developed an extended 14-day protocol for the pre-culture of bone-like and cartilage-like micropellets in their respective induction medium. Unified osteochondral tissues were formed by layering 12,000 osteogenic micropellets and 12,000 chondrogenic micropellets into a biphasic structure and then further culture in chondrogenic induction medium. The assembled tissue was cultured for a further 8 days and characterized via histology. The micropellets had amalgamated into a continuous structure with distinctive bone-like and cartilage-like regions. This proof-of-concept study demonstrates the feasibility of micropellet assembly for the formation of osteochondral-like tissues for possible use in osteochondral defect repair. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00441-015-2159-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4550660
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-45506602015-08-28 High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue Babur, Betul Kul Futrega, Kathryn Lott, William B. Klein, Travis Jacob Cooper-White, Justin Doran, Michael Robert Cell Tissue Res Regular Article Engineered biphasic osteochondral tissues may have utility in cartilage defect repair. As bone-marrow-derived mesenchymal stem/stromal cells (MSC) have the capacity to make both bone-like and cartilage-like tissues, they are an ideal cell population for use in the manufacture of osteochondral tissues. Effective differentiation of MSC to bone-like and cartilage-like tissues requires two unique medium formulations and this presents a challenge both in achieving initial MSC differentiation and in maintaining tissue stability when the unified osteochondral tissue is subsequently cultured in a single medium formulation. In this proof-of-principle study, we used an in-house fabricated microwell platform to manufacture thousands of micropellets formed from 166 MSC each. We then characterized the development of bone-like and cartilage-like tissue formation in the micropellets maintained for 8–14 days in sequential combinations of osteogenic or chondrogenic induction medium. When bone-like or cartilage-like micropellets were induced for only 8 days, they displayed significant phenotypic changes when the osteogenic or chondrogenic induction medium, respectively, was swapped. Based on these data, we developed an extended 14-day protocol for the pre-culture of bone-like and cartilage-like micropellets in their respective induction medium. Unified osteochondral tissues were formed by layering 12,000 osteogenic micropellets and 12,000 chondrogenic micropellets into a biphasic structure and then further culture in chondrogenic induction medium. The assembled tissue was cultured for a further 8 days and characterized via histology. The micropellets had amalgamated into a continuous structure with distinctive bone-like and cartilage-like regions. This proof-of-concept study demonstrates the feasibility of micropellet assembly for the formation of osteochondral-like tissues for possible use in osteochondral defect repair. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00441-015-2159-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-04-30 2015 /pmc/articles/PMC4550660/ /pubmed/25924853 http://dx.doi.org/10.1007/s00441-015-2159-y Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Regular Article
Babur, Betul Kul
Futrega, Kathryn
Lott, William B.
Klein, Travis Jacob
Cooper-White, Justin
Doran, Michael Robert
High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title_full High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title_fullStr High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title_full_unstemmed High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title_short High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
title_sort high-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550660/
https://www.ncbi.nlm.nih.gov/pubmed/25924853
http://dx.doi.org/10.1007/s00441-015-2159-y
work_keys_str_mv AT baburbetulkul highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue
AT futregakathryn highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue
AT lottwilliamb highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue
AT kleintravisjacob highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue
AT cooperwhitejustin highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue
AT doranmichaelrobert highthroughputboneandcartilagemicropelletmanufacturefollowedbyassemblyofmicropelletsintobiphasicosteochondraltissue